» Articles » PMID: 19858395

Evidence-based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2009 Oct 28
PMID 19858395
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The uptake of new health care technologies is usually driven by industry promotion, physician interest, patient demand, and institutional ability to acquire the technology. The introduction of positron emission tomography (PET) scanning in the province of Ontario, Canada, followed a different path.

Methods: The Ontario provincial government, through its Ministry of Health and Long-Term Care, commissioned a systematic review of the literature. When this found only weak evidence that PET has a positive impact on clinical outcomes, the Ministry introduced a provincial PET evaluation program to close the evidence gap.

Results: This article describes the challenges encountered establishing the PET evaluation program. These included the design and conduct of the initial clinical trials, the establishment of a PET cancer registry, standardizing how PET scans were performed and reported, and gaining acceptance by health professionals for the evaluative program.

Conclusion: The proliferation of health technologies is a key driver of increasing health care costs. The Ontario approach to the introduction of PET is a model worth consideration by health systems seeking to ensure that they receive value for money based on a strong evidentiary base when introducing new health technologies.

Citing Articles

Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada.

Young S, Metser U, Sistani G, Langer D, Bauman G Front Oncol. 2021; 11:722430.

PMID: 34408985 PMC: 8366560. DOI: 10.3389/fonc.2021.722430.


Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.

Elit L, Fyles A, Gu C, Pond G, DSouza D, Samant R JAMA Netw Open. 2019; 1(5):e182081.

PMID: 30646153 PMC: 6324512. DOI: 10.1001/jamanetworkopen.2018.2081.


Setting a research agenda for medical overuse.

Morgan D, Brownlee S, Leppin A, Kressin N, Dhruva S, Levin L BMJ. 2015; 351:h4534.

PMID: 26306661 PMC: 4563792. DOI: 10.1136/bmj.h4534.


(18)F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer.

You J, Cline K, Gu C, Pritchard K, Dayes I, Gulenchyn K Br J Cancer. 2015; 112(11):1737-43.

PMID: 25942398 PMC: 4647251. DOI: 10.1038/bjc.2015.151.


An assessment of the characteristics and quality of diagnostic accuracy studies for positron emission tomography conducted in Japan: a systematic review.

Nomura S, Hisashige A, Yoneoka D, Kanda M, Miyamoto K, Segawa M EJNMMI Res. 2015; 5:6.

PMID: 25853012 PMC: 4385095. DOI: 10.1186/s13550-015-0084-4.